Tangeretin overcomes drug resistance by inhibiting Nrf2 and increases the intracellular accumulation of drugs by inhibiting Nrf2/P-gp, thus making lung cancer cells sensitive to chemotherapy drugs. The gene discussed is NFE2L2; the disease is lung cancer.